Mangia A - Search Results

1

Hepatitis C virus micro-elimination: Where do we stand?

Mangia A, Cotugno R, Cocomazzi G, Squillante MM, Piazzolla V. Mangia A, et al. World J Gastroenterol. 2021 Apr 28;27(16):1728-1737. doi: 10.3748/wjg.v27.i16.1728. World J Gastroenterol. 2021. PMID: 33967553 Free PMC article. Review.

2

Gallbladder emptying in patients with primary achalasia.

Caturelli E, Squillante MM, Fusilli S, Aliotta A, Cellerino C, Mangia A, Gabbrielli L. Caturelli E, et al. Among authors: mangia a. Digestion. 1992;52(3-4):152-6. doi: 10.1159/000200947. Digestion. 1992. PMID: 1459348

3

Cruveilhier-Baumgarten syndrome without esophageal varices: ultrasonographic diagnosis and echo-Doppler study.

Caturelli E, Sperandeo G, Squillante MM, Mangia A, Gabbrielli L. Caturelli E, et al. Among authors: mangia a. J Clin Gastroenterol. 1989 Jun;11(3):357-61. J Clin Gastroenterol. 1989. PMID: 2666500

4

External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.

Iacobellis A, Mangia A, Leandro G, Clemente R, Festa V, Attino V, Ricciardi R, Giacobbe A, Facciorusso D, Andriulli A. Iacobellis A, et al. Among authors: mangia a. Am J Gastroenterol. 2005 Apr;100(4):868-73. doi: 10.1111/j.1572-0241.2005.40881.x. Am J Gastroenterol. 2005. PMID: 15784034 No abstract available.

5

Short-duration therapy for hepatitis C: suitable for all?

Mangia A. Mangia A. J Viral Hepat. 2007 Apr;14(4):221-7. doi: 10.1111/j.1365-2893.2006.00817.x. J Viral Hepat. 2007. PMID: 17381713 Review.

6

Hepatitis C infection in patients with chronic kidney disease.

Mangia A, Burra P, Ciancio A, Fagiuoli S, Guido M, Picciotto A, Fabrizi F; Italian Association for The Study of The Liver (A.I.S.F). Mangia A, et al. Int J Artif Organs. 2008 Jan;31(1):15-33. doi: 10.1177/039139880803100104. Int J Artif Organs. 2008. PMID: 18286451 Review.

7

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection.

Mangia A, Minerva N, Bacca D, Cozzolongo R, Agostinacchio E, Sogari F, Scotto G, Vinelli F, Ricci GL, Romano M, Carretta V, Petruzzellis D, Andriulli A. Mangia A, et al. Hepatology. 2009 Feb;49(2):358-63. doi: 10.1002/hep.22679. Hepatology. 2009. PMID: 19072829

8

Tailoring the length of antiviral treatment for hepatitis C.

Mangia A, Andriulli A. Mangia A, et al. Gut. 2010 Jan;59(1):1-5. doi: 10.1136/gut.2009.179606. Gut. 2010. PMID: 20007952 Review. No abstract available.

9

Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin.

Mangia A, Dalgard O, Minerva N, Verbaan H, Bacca D, Ring-Larsen H, Copetti M, Carretta V, Piazzolla V, Cozzolongo R, Mottola L, Andriulli A. Mangia A, et al. Aliment Pharmacol Ther. 2010 Jun;31(12):1346-53. doi: 10.1111/j.1365-2036.2010.04290.x. Epub 2010 Mar 8. Aliment Pharmacol Ther. 2010. PMID: 20222909 Free article.

10

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.

Mangia A, Thompson AJ, Santoro R, Piazzolla V, Tillmann HL, Patel K, Shianna KV, Mottola L, Petruzzellis D, Bacca D, Carretta V, Minerva N, Goldstein DB, McHutchison JG. Mangia A, et al. Gastroenterology. 2010 Sep;139(3):821-7, 827.e1. doi: 10.1053/j.gastro.2010.05.079. Epub 2010 Jun 2. Gastroenterology. 2010. PMID: 20621700 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page